Gilead Sciences, Inc. GILD obtained FDA approval for its twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, for the ...

As the world watches the International Space Station orbit above us, a historic mission awaits its moment to launch. The ...

The decision comes as the company is discontinuing clinical testing of a CLDN6-targeted CAR T-cell therapy in testicular cancer.

Key Takeaways in this ArticleThe global Artificial Intelligence in Genomics market is valued at USD 785.12 million in 2024 ...

Navigating the Artificial Blood Cells MarketIn the landscape of modern medicine, few innovations hold the transformative ...

An Irish woman who headed Ireland’s medicine’s watchdog has been appointed to take over as Executive Director of the European ...

Warning as softgel capsule supplements linked to range of health concerns - The smooth, easy-to-swallow capsules have come ...

Researchers have found in a large study that among cognitively unimpaired individuals there was a notable number of positive ...

India's equity benchmarks remained muted on Thursday, as cautious signals from the U.S. Federal Reserve and ongoing ...